AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Carlat Psychiatry Podcast
MDMA: What Went Wrong Part 2
Jun 17, 2024
Psychiatrist Chris Aiken and PMHNP Kellie Newsome discuss the recent FDA rejection of MDMA therapy for PTSD, exploring issues like boundary violations and functional unblinding. They analyze biases in medication trials, potential risks of MDMA, and the advocacy for its medical use in treating PTSD. The podcast also explores cardiovascular risks of MDMA, therapist influence on patient outcomes, and the need for standardized evaluation methods.
26:59
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- MDMA-assisted therapy faced FDA rejection due to concerns over boundary violations and functional unblinding.
- Challenges in assessing efficacy and biases hindered the approval of MDMA for PTSD therapy.
Deep dives
MDMA-Assisted Therapy Rejected by FDA Panel
The FDA panel voted against approving MDMA-assisted psychotherapy for PTSD, citing concerns such as sexual boundary violations and functional unblinding. Despite a chance for approval, a majority of panel members were against it, with worries about potential biases affecting patient experiences and reporting of symptoms.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode